Edwards Lifesciences

Yahoo Finance • 10 days ago

Edwards Lifesciences upgraded at JP Morgan on TAVR, TMTT strength

[Wall Street sign in Lower Manhattan, NYC] georgeclerk JP Morgan upgraded Edwards Lifesciences (EW [https://seekingalpha.com/symbol/EW]) to overweight from neutral highlighting accelerating growth in its transcatheter aortic valve replace... Full story

Yahoo Finance • 10 days ago

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., December 18, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026. Bernard Zovighian, chief executive offi... Full story

Yahoo Finance • 23 days ago

Sector Update: Health Care Stocks Lower Late Afternoon

Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 0.3% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • last month

Edwards Lifesciences' (NYSE:EW) investors will be pleased with their 20% return over the last year

If you want to compound wealth in the stock market, you can do so by buying an index fund. But investors can boost returns by picking market-beating companies to own shares in. For example, the Edwards Lifesciences Corporation (NYSE:EW) sh... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: UNH, Eli Lilly and Merck in focus

Wall Street rallied higher as investors digested upbeat earnings from big tech companies during the week. The Nasdaq gained 2.2%, the S&P 500 moved up by 0.7%, and the Dow added 0.7% this week. However, the S&P 500 Health Care Index Sect... Full story

Yahoo Finance • 2 months ago

Closing Bell Movers: Amazon soars to all-time highs on earnings

In the opening hour of the evening session, U.S. equity futures are notably higher, with S&P 500 up 0.5% and Nasdaq 100 contracts up 1.0%.  In commodities, WTI Crude Oil is little changed just above $60 per barrel while precious metals are... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences raises 2025 guidance to high end of 9–10% sales growth and $2.56–$2.62 EPS amid strong Q3

Earnings Call Insights: Edwards Lifesciences (EW) Q3 2025 MANAGEMENT VIEW * CEO Bernard Zovighian opened the call by stating, "We are pleased with the year-to-date performance of the company, including the most recent third quarter, ou... Full story

Yahoo Finance • 2 months ago

Edwards Lifesciences Announces CFO Transition Plan

IRVINE, Calif., October 30, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that Scott Ullem, the company’s chief financial officer, has decided to transition from his role by midyear 2026. While the company initiate... Full story

Yahoo Finance • 2 months ago

Skyworks upgraded, UnitedHealth downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Piper Sandler upgraded Skyworks (SWKS)... Full story

Yahoo Finance • 2 months ago

EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE:... Full story

Yahoo Finance • 2 months ago

Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025

SAPIEN 3, which showed superiority at 1 year, also demonstrates compelling outcomes equivalent to surgery at seven years SAN FRANCISCO, October 27, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced seven-year data fro... Full story

Yahoo Finance • 2 months ago

Cardiovascular Repair & Reconstruction Devices - Global Market Forecast (2025-2032) Featuring Profiles of Medtronic, Edwards Lifesciences, Abbott Labs, Boston Scientific, Terumo and More

Company Logo The cardiovascular repair market is fueled by an aging population, technological advancements, and the rise in comorbidities. Opportunities lie in innovative, minimally invasive devices, value-based contracting, and regional... Full story

Yahoo Finance • 2 months ago

GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex

Company Logo The GCC catheter market is projected to grow from USD 579.83 million in 2024 to USD 1.28 billion by 2033, with a CAGR of 9.21% from 2025 to 2033. This growth is driven by an increase in chronic diseases, surgical procedures,... Full story

Yahoo Finance • 2 months ago

Piper Sandler Maintains Overweight on Edwards Lifesciences (EW) Ahead of PARTNER 3 7-Year Results

Edwards Lifesciences Corporation (NYSE:EW) ranks among the best medical device stocks to invest in. Piper Sandler maintained its Overweight rating and $90 price target for Edwards Lifesciences Corporation (NYSE:EW) on October 7, ahead of t... Full story

Yahoo Finance • 3 months ago

Abbott Laboratories Still Offers Attractive Valuation, UBS Says

Abbott Laboratories' (ABT) diabetes, electrophysiology, and structural heart businesses' growth outl PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Stocks Climb as AI Investment Accelerates

The S&P 500 Index ($SPX) (SPY) today is up +0.36%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.19%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.57%.  December E-mini S&P futures (ESZ25) are up +0.39%, and December E-mini Nas... Full story

Yahoo Finance • 3 months ago

Edwards Lifesciences slips as Oppenheimer downgrades on upcoming data

[Business on Wall Street in Manhattan] Pgiam/iStock via Getty Images Shares of Edwards Lifesciences (NYSE:EW [https://seekingalpha.com/symbol/EW]) fell on Wednesday after Oppenheimer downgraded the cardiac device maker to Perform from Out... Full story

Yahoo Finance • 3 months ago

Stocks Supported by AI Optimism and Lower Bond Yields

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is up +0.38%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures/q... Full story

Yahoo Finance • 3 months ago

Intel, FedEx downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Deutsche Bank upgraded Northrop Grumma... Full story

Yahoo Finance • 3 months ago

Edwards Lifesciences upgraded at Evercore on upcoming 'topline inflection'

[Edwards Lifesciences facility in Draper, Utah, USA] JHVEPhoto/iStock Editorial via Getty Images * Evercore ISI upgraded Edwards Lifesciences (NYSE:EW [https://seekingalpha.com/symbol/EW]) to outperform from equalweight to outperform as... Full story